FLOW: Semaglutida reduz desfechos renais em pacientes com diabetes tipo 2 e DRC episode artwork

EPISODE · May 15, 2025 · 7 MIN

FLOW: Semaglutida reduz desfechos renais em pacientes com diabetes tipo 2 e DRC

from Afya Endocrinopapers · host Afya Endocrinopapers

Nesta aula, comentamos os resultados do estudo FLOW, que demonstrou a redução de desfechos renais com o uso da semaglutida em pacientes com diabetes tipo 2 e doença renal crônica.Endocrinologia descomplicada para médicos e residentes.Aqui você encontra conteúdos sobre atualização médica, casos clínicos e preparação para provas de título.📚 Aprofunde seus estudos com nossos cursos e materiais: https://papers.afya.com.br/endocrinopapers📲 Siga-nos no Instagram: @afyaendocrinopapers🔔 Inscreva-se no canal e ative as notificações para não perder nenhuma atualização!

Episode metadata supplied by the publisher feed · Published May 15, 2025

Embed this episode

NOW PLAYING

FLOW: Semaglutida reduz desfechos renais em pacientes com diabetes tipo 2 e DRC

0:00 7:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Afya Endocrinopapers?

This episode is 7 minutes long.

When was this Afya Endocrinopapers episode published?

This episode was published on May 15, 2025.

Can I download this Afya Endocrinopapers episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!